Travere Therapeutics, Inc.
TVTX
$15.29
-$1.27-7.67%
| Weiss Ratings | TVTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | TVTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TVTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.02 | |||
| Price History | TVTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -26.38% | |||
| 30-Day Total Return | -30.37% | |||
| 60-Day Total Return | -19.79% | |||
| 90-Day Total Return | -16.18% | |||
| Year to Date Total Return | -19.32% | |||
| 1-Year Total Return | 120.22% | |||
| 2-Year Total Return | -29.89% | |||
| 3-Year Total Return | -47.22% | |||
| 5-Year Total Return | -4.88% | |||
| 52-Week High % Change | -34.52% | |||
| 52-Week Low % Change | 223.44% | |||
| Price | TVTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $25.29 | |||
| 52-Week Low Price | $5.12 | |||
| 52-Week Low Price (Date) | Apr 25, 2024 | |||
| 52-Week High Price (Date) | Feb 11, 2025 | |||
| Valuation | TVTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.47B | |||
| Enterprise Value | 1.50B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -4.10 | |||
| Earnings Per Share Growth | 156.92% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 5.90 | |||
| Price/Book (Q) | 24.52 | |||
| Enterprise Value/Revenue (TTM) | 6.43 | |||
| Price | $15.31 | |||
| Enterprise Value/EBITDA (TTM) | -5.40 | |||
| Enterprise Value/EBIT | -4.67 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | TVTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 83.11M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TVTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 888 969 7879 | |||
| Address | 3611 Valley Centre Drive San Diego, CA 92130 | |||
| Website | www.travere.com | |||
| Country | United States | |||
| Year Founded | 2008 | |||
| Profitability | TVTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -137.83% | |||
| Profit Margin | -137.89% | |||
| Management Effectiveness | TVTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -29.05% | |||
| Return on Equity | -- | |||
| Income Statement | TVTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 233.18M | |||
| Total Revenue (TTM) | 233.18M | |||
| Revenue Per Share | $2.81 | |||
| Gross Profit (TTM) | 7.94M | |||
| EBITDA (TTM) | -277.83M | |||
| EBIT (TTM) | -321.39M | |||
| Net Income (TTM) | -321.55M | |||
| Net Income Avl. to Common (TTM) | -321.55M | |||
| Total Revenue Growth (Q YOY) | 65.98% | |||
| Earnings Growth (Q YOY) | 31.97% | |||
| EPS Diluted (TTM) | -4.10 | |||
| EPS Diluted Growth (Q YOY) | 38.50% | |||
| Balance Sheet | TVTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 370.70M | |||
| Cash Per Share (Q) | $4.46 | |||
| Total Current Assets (Q) | 416.70M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 59.08M | |||
| Current Ratio (Q) | 2.076 | |||
| Book Value Per Share (Q) | $0.68 | |||
| Total Assets (Q) | 594.13M | |||
| Total Current Liabilities (Q) | 200.75M | |||
| Total Debt (Q) | 401.58M | |||
| Total Liabilities (Q) | 535.05M | |||
| Total Common Equity (Q) | 59.08M | |||
| Cash Flow | TVTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 99.33M | |||
| Cash from Financing (TTM) | 139.42M | |||
| Net Change in Cash (TTM) | 359.00K | |||
| Levered Free Cash Flow (TTM) | -269.28M | |||
| Cash from Operations (TTM) | -237.48M | |||
